Labshake search
Citations for R&D Systems :
1 - 50 of 10000+ citations for 7 Amino 1 3 dimethyl 1H 8H pyrido 2 3 d pyrimidine 2 4 5 trione since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2021Quote: Cells were grown to 70% confluent in 24-well plates prior to treatment with N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89; R&D Systems) or 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde (KNK437 ...
-
bioRxiv - Genomics 2024Quote: ... M anti-DENV NS1 (Type 2/3/4) (Cat# MAB94441-100, R&D Systems), M anti-NXT1 (Cat#67680-1-Ig ...
-
bioRxiv - Neuroscience 2024Quote: ... cultures were cotreated with 20 nM (2S,3S)-2-Amino-3-methyl-N-[2-(4-morpholinyl)ethyl]pentanamide dihydrochloride (LM11a-31)(R&D Systems, Minneapolis, MN, USA, Cat no: 5046) or vehicle solution consisting of DMSO during application of 6-OHDA ...
-
bioRxiv - Immunology 2020Quote: ... the media were refreshed and supplemented with 5 ng/mL IL-7 or 5 ng/mL IL-7 and 4 ng/ml IL-2 (R&D Systems), respectively ...
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Immunology 2024Quote: ... from 2-3 donors towards CXCL2 (R&D Systems, cat. 276-GB-010) and RARRES2 (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs from healthy individuals were isolated and expanded in vitro for 7 days in the presence of 50 ng/ml of OKT-3 (Miltenyi) and 600 IU/ml IL-2 (R&D Systems) in AIM-V (Gibco ...
-
bioRxiv - Immunology 2023Quote: ... 2 ng/mL of IL-2 and 3 ng/mL of TGFβ (R&D systems, 7666-MB-055)) conditions ...
-
bioRxiv - Cancer Biology 2022Quote: ... Digested cells were washed three times with PBS and resuspended in 2/3 Cultrex Type 2 (R&D Systems) and 1/3 Full Ad-DF+++ medium and plated in drops which were allowed to solidify for 30 minutes at 37°C after which they were overlayed with Full Ad-DF+++ medium ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Neuroscience 2022Quote: ... sonic hedgehog C25II (days 2-7, 100ng/mL, R&D Systems). After day 13 of differentiation ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 ng/mL recombinant murine IL-3 (R&D Systems, and 5% stem cell factor-containing supernatant from CHO-KL cells for 4-6 weeks until maturation ...
-
bioRxiv - Bioengineering 2020Quote: ... Mouse IL-28 A/B (IFN-lambda 2/3) Du-oSet ELISA (DY1789B, R&D Systems), was used to assess cross-reactivity.
-
bioRxiv - Microbiology 2021Quote: ... ULBP-2/5/6 (65903, R&D systems), Plexin-B1 (rea728 ...
-
bioRxiv - Molecular Biology 2023Quote: ... 5 ng/ml FGF-2 (R&D Systems) and 1 μM CHIR99021 (STEMCELL Technologies) ...
-
bioRxiv - Immunology 2020Quote: ... 3 and 4 were measured using Luminex technology (R&D Systems), according to the manufacturer’s protocols ...
-
bioRxiv - Developmental Biology 2021Quote: ... 3 µM ZM306416 (R&D Systems, 2499/1) and 10 µM of SU5402 (R&D Systems ...
-
bioRxiv - Physiology 2022Quote: ... rhuIL-3 (1 ng/ml, R&D Systems). Erythropoiesis was induced by addition of 3 U/ml recombinant human erythropoietin (rEPO ...
-
bioRxiv - Cancer Biology 2022Quote: ... Caspase 3 (R&D Systems AF835, 1:800). The sections were then incubated with appropriate secondary antibodies for 30 minutes at room temperature ...
-
bioRxiv - Genetics 2021Quote: ... 3 ng/ml mouse IL-3 (R&D Systems) and 20% L-cell conditioned medium ...
-
bioRxiv - Developmental Biology 2020Quote: ... or Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3) was placed in the upper and lower chambers ...
-
bioRxiv - Developmental Biology 2024Quote: ... EBs were split 1:2 in SF-D media containing rhVEGF (5 ng ml-1; R&D Systems), rhBMP4 (10 ng ml-1 ...
-
bioRxiv - Developmental Biology 2024Quote: ... EBs were split 1:3 in SF-D media containing recombinant human (rh) VEGF (5 ng ml-1; R&D Systems), rhBMP4 (10 ng ml-1 ...
-
bioRxiv - Bioengineering 2022Quote: ... and 5 ng/mL FGF-2 (R&D systems) (MSC expansion media).
-
bioRxiv - Immunology 2024Quote: ... the medium was enriched with recombinant murine interleukin-3 (IL-3; 5 ng/mL) and stem cell factor (SCF; 5 ng/mL) from R&D Systems, Minneapolis ...
-
bioRxiv - Neuroscience 2022Quote: ... and Neurotrophin-3 (NT-3, 20ng/ml, R&D systems) were used for neural differentiation between days 27 and 41 ...
-
bioRxiv - Bioengineering 2022Quote: ... α3 (MAB1345; R&D systems), β4 (NBP1-43369) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Type 3 (R&D Systems); coenzyme Q10 (CoQ) ...
-
bioRxiv - Cancer Biology 2021Quote: ... active caspase-3 (R&D Systems AF835; 1:50), and Vimentin (CST 5741 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and caspase-3 (1:2000, AF835, R&D Systems) on a Ventana Benchmark Ultra automated staining system (Roche) ...
-
bioRxiv - Developmental Biology 2023Quote: ... VEGFR-3 (AF349, R&D Systems, 1:100, RRID:AB_355314), Coup-TF2 (EPR18443 ...
-
bioRxiv - Cell Biology 2023Quote: ... GLI-3 (AF3690, R&D Systems, dilution 1:500), RAB11FIP5 (14594-1-AP ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197), anti-Hsp70 (1:300 ...
-
bioRxiv - Cell Biology 2023Quote: ... and 1 ng/ml IL-3 (R&D Systems) to induce cell proliferation ...
-
bioRxiv - Cancer Biology 2021Quote: ... 3 µg/mL anti-ULBP2/5/6 (clone 165903, R&D Systems), and 6 µg/mL anti-ULBP3 (clone 166510 ...
-
bioRxiv - Bioengineering 2022Quote: ... and interleukin-3 (IL-3) were purchased from R&D Systems.
-
bioRxiv - Cancer Biology 2022Quote: ... human interleukin-3 (IL-3, 10 ng/mL, R&D Systems), human interleukin-6 (IL-6 ...
-
bioRxiv - Bioengineering 2023Quote: ... and further supplemented with 5 ng ml -1 of FGF-2 (R&D Systems). Medium was changed twice a week ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were cultured for 4 days with 3 μM CHIR (R&D Systems); 3 days with 200 ng/mL FGF9 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2023Quote: The blots were probed overnight at 4°C with monoclonal mouse anti-β-Catenin (2 µg/mL in Bovine Serum Albumin 3%, R&D Systems, Minneapolis, USA, #MAB1329), monoclonal rabbit anti-NDRG4 (1:1000 ...
-
bioRxiv - Cell Biology 2021Quote: ... cleaved Caspase 3 (rabbit, R&D systems MAB835, 1:500), CPE (rabbit ...
-
bioRxiv - Microbiology 2022Quote: ... and anti-Tyro-3 (1:1000, R&D Systems, MAB859100) antibodies ...
-
bioRxiv - Neuroscience 2022Quote: ... washed 3× in 1× wash buffer (895003, R&D Systems), blocked in 1% BSA for 1 hour at room temperature (RT) ...
-
bioRxiv - Cancer Biology 2024Quote: ... polyclonal anti-caspase-3 (1:1000; R&D Systems GmbH), polyclonal anti-LC3 (1:1000 ...
-
bioRxiv - Molecular Biology 2020Quote: Randomly selected sections coming from ovarian tissue of least 3 different individuals were used for immunohistochemistry for Anti-active Caspase-3 (AC-3, 1:1000, AF-835, R&D Systems), γH2AX (1:250 IHC-00059 ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... caspase-3 (R&D Systems, AF835), Endomucin (Santa Cruz ...
-
bioRxiv - Developmental Biology 2024Quote: ... 3 µM CHIR (R&D Systems), 10 mM A83-01 (Tocris ...
-
bioRxiv - Developmental Biology 2024Quote: ... SSEA-3 (R&D Systems, MAB1434) and Alexa Fluor 594 conjugated SSEA-4 (BioLegend ...
-
bioRxiv - Immunology 2022Quote: ... 5 ng/ml IL-7 (R&D Systems), 5 ng/ml IL-15 (R&D Systems) ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... or recombinant human cathepsin L (CatL, 2 ng/ul, pH 5.5, 37°C for 1h; R&D Systems) as described previously (5) ...